Trials / Recruiting
RecruitingNCT02770066
A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension
A Prospective Danish National Registry of Percutaneous Transluminal Renal Angioplasty in Patients With Renovascular Hypertension
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 160 (estimated)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A prospective Danish national registry of percutaneous transluminal renal angioplasty (PTRA) in high-risk patients with renal artery stenosis selected on the basis of common national criteria, and with a common follow-up protocol for all three Danish centres offering PTRA
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Percutaneous transluminal renal angioplasty | Angioplasty plus stenting (angioplasty in patients with fibromuscular dysplasia) Adjuvant therapy in atherosclerotic renal artery stenosis - at the discretion of the treating physician * Antiplatelet therapy (usually standard) * Cholesterol-lowering drugs (usually standard) * Antihypertensive treatment with angiotensin-converting-enzyme inhibitor or angiotensin-receptor blocker (normally not contraindicated) * Smoking cessation, diet and physical activity (usually standard) |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2030-01-01
- Completion
- 2035-01-01
- First posted
- 2016-05-12
- Last updated
- 2025-12-18
Locations
5 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02770066. Inclusion in this directory is not an endorsement.